Skip to main content
SpringerLink
Log in

Cost-effectiveness analysis for management of patients with ischemic heart disease

  • Editorial
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kupersmith J, Holmes-Rovner M, Hogan A. Cost-effectiveness analysis. Am Heart Assoc (Clin Cardiol Series) 1995;6:10.

    Google Scholar 

  2. Mark DB, Hlatky MA, Califf RM, et al. Cost-effectiveness of thrombolytic therapy with tissue-plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418–24.

    Article  PubMed  CAS  Google Scholar 

  3. Lee TH. Cost-effectiveness of tissue-plasminogen activator. {Editorial} N Engl J Med 1995;332:1443–4.

    Article  PubMed  CAS  Google Scholar 

  4. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single-photon emission computed tomography, positron emission tomography and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54–65.

    PubMed  CAS  Google Scholar 

  5. Task force on principles for economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61–70.

    Google Scholar 

  6. Patterson RE, Horowitz SF, Gorlin R, Goldstein R. Bayesian comparison of cost-effectiveness of different clinical approaches to diagnose coronary artery disease. J Am Coll Cardiol 1984;4:278–89.

    Article  PubMed  CAS  Google Scholar 

  7. Goldman L, Sia STB, Cook EF, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 1988;319:152–7.

    PubMed  CAS  Google Scholar 

  8. Diamond GA, Denton TA. Alternative perspectives on the biased foundations of medical technology assessment. Ann Intern Med 1993;118:455–64.

    PubMed  CAS  Google Scholar 

  9. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991;265:1145–51.

    Article  PubMed  CAS  Google Scholar 

  10. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise-induced ST depression in the diagnosis of coronary artery disease: a meta analysis. Circulation 1989;80:87–94.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Presbyterian Medical Center, Philadelphia Heart Institute, 51 N. 39th St., 19104, Philadelphia, PA

    Abdulmassih S. Iskandrian

Authors
  1. Abdulmassih S. Iskandrian
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by the Sidney Kimmel Cardiovascular Research Center.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iskandrian, A.S. Cost-effectiveness analysis for management of patients with ischemic heart disease. J Nucl Cardiol 2, 544–546 (1995). https://doi.org/10.1016/S1071-3581(05)80046-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(05)80046-7

Search

Navigation